Challenges posed by the scale-up of nanomedicines

Nanomedicine

Volumn 7, Issue 3, 2012, Pages 307-309

  Muthu, Madaswamy S ^a   Wilson, Barnabas ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b Dayananda Sagar University   (India)

Author keywords

emulsion based method; large scale production; nanoprecipitation method; polymeric nanoparticles; solid lipid nanoparticles

Indexed keywords

CARBON NANOTUBE; DENDRIMER; DOXORUBICIN; LIPOSOME; NANOPARTICLE; PACLITAXEL; POLYMER;

BREAST CANCER; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; DRUG STABILITY; EMULSION; GELATION; MICELLE; NANOENCAPSULATION; NANOMEDICINE; OVARY CANCER; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; REVIEW;

NANOMEDICINE; NANOSTRUCTURES; NANOTECHNOLOGY;

EID: 84857875984     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.3     Document Type: Review

References (14)

1. Muthu MS, Rajesh CV, Mishra A, Singh S. Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine (Lond.) 4(6), 657-667 (2009).
2. Muthu MS, Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine (Lond.) 4(1), 105-118 (2009). Describes the types of nanomedicines and their role for future therapy.
3. Muthu MS, Singh S. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine (Lond.) 3(3), 305-319 (2008).
4. Muthu MS, Feng SS. Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine (Lond.) 5(7), 1017-1019 (2010).
5. Muthu MS, Wilson B. Multifunctional radionanomedicine: A novel platform for effective cancer imaging and therapy. Nanomedicine (Lond.) 5(2), 169-171 (2010).
6. Kulkarni SA, Feng SS. Effect of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier. Nanomedicine (Lond.) 6(2), 377-394 (2011).
7. Muthu MS, Kulkarni SA, Raju A, Feng SS. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials doi:10.1016/j.biomaterials.2012.01.036 (2012) (In Press).
8. Saraf S. Process optimization for the production of nanoparticles for drug delivery applications. Expert Opin. Drug Deliv. 6, 187-196 (2009).
9. Galindo-Rodriquez S, Puel F, Briancon S, Allemann E, Doelker E, Fessi H. Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur. J. Pharm. Sci. 25, 357-367 (2005).
10. Charcosset C, Fessi H. A new process for drug loaded nanocapsules preparation using a membrane contactor. Drug Dev. Ind. Pharm. 31, 987-992 (2005).
11. Colombo AP, Briancon S, Lieto J, Fessi H. Project, design, and use of a pilot plant for nanocapsule production. Drug Dev. Ind. Pharm. 27, 1063-1072 (2001).
12. El-Harati AA, Charcosset C, Fessi H. Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor. Pharm. Dev. Technol. 11, 153-157 (2006).
13. Muthu MS, Feng SS. Pharmaceutical stability aspects of nanomedicines. Nanomedicine (Lond.) 4(8), 857-860 (2009).
14. Wilson B. Therapeutic compliance of nanomedicine in Alzheimer's disease. Nanomedicine (Lond.) 6(7), 1137-1139 (2011).